[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
Baraia-Etxaburu
J
J
Malero
P
P
Unzaga
M J
MJ
Teira
R
R
Muñoz
J
J
Cisterna
R
R
Santamaría
J M
JM
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000193:Actinomycetales Infections / Q000188:drug therapy*; D000328:Adult; D002939:Ciprofloxacin / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D004917:Erythromycin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D016929:Rhodococcus equi / Q000187:drug effects / Q000302:isolation & purification; D012293:Rifampin / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
D005839:Gentamicins; D002939:Ciprofloxacin; D004917:Erythromycin; D014640:Vancomycin; D017291:Clarithromycin; D012293:Rifampin